MRMD (MariMed) Forward Dividend Yield %: 0.00% (As of Jun. 26, 2026)


What is MariMed Forward Dividend Yield %?

MariMed MRMD +0.27% Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. The stock has 5 warning signs investors should review. Among 504 Drug Manufacturers companies, MariMed ranks worse than 198412.5% on this metric.

As of today (2026-06-26), the Forward Annual Dividend Yield of MariMed is 0.00%.

As of today (2026-06-26), the Trailing Annual Dividend Yield of MariMed is 0.00%.

MRMD's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.08
* Ranked among companies with meaningful Forward Dividend Yield % only.

MariMed's Dividends per Share for the three months ended in Mar. 2026 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

MariMed  (OTCPK:MRMD) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

MariMed Forward Dividend Yield % Related Terms

MRMD vs CPHI, RMTI, HYEX: Forward Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, MariMed's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MariMed Forward Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MariMed's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where MariMed's Forward Dividend Yield % falls into.


MariMed Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
MariMed (MRMD) has a Forward Dividend Yield % of 0.00% as of Jun. 26, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on MariMed and its competitors. According to the industry distribution chart, MariMed ranks #999999 out of 504 companies in the Drug Manufacturers industry.
Is MariMed's Forward Dividend Yield % too high?
MariMed's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, MariMed ranks #999999 out of 504 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does MariMed's Forward Dividend Yield % compare to CPHI and RMTI?
According to the Drug Manufacturers industry distribution chart, MariMed ranks #999999 out of 504 companies for Forward Dividend Yield %. This places MariMed in the lower half of its industry. The industry median Forward Dividend Yield % is 2.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.08, based on 504 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on MariMed and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MariMed's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MariMed stock overvalued right now?
Based on GuruFocus' analysis, MariMed (MRMD) is currently considered Possible Value Trap. The stock's GF Value™ is $0.16, compared to a current price of $0.07 — trading 54.4% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For MariMed (MRMD), the current Forward Dividend Yield % is 0.00% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MariMed Business Description

Other Exchanges MRMD:Canada
Address 10 Oceana Way, Floor 2, Norwood, MA, USA, 02062
MariMed Inc is a multi-state cannabis operator in the United States dedicated to improving lives every day through its high-quality products. The company develops, owns, and manages seed to sale state-licensed, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. It has created and continues to develop its own brands of cannabis flower, concentrates, edibles, and other precision-dosed products utilizing its proprietary strains and formulations. The company also licenses its proprietary brands, along with other top cannabis products, in select domestic markets. Its operations are conducted in compliance with applicable state and local laws and regulations in the jurisdictions in which it operates.